Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers

Serbia to Start Sale of Galenika Drugmaker in Early 2013

Serbia plans to start the sale of its drugmaker Galenika AD in early 2013, the government said in an e-mailed statement today.

The state may offer a stake in the Zemun, Serbia-based company to the European Bank for Reconstruction and Development, General Manager Zivomir Novakovic said on Oct. 30.

The company posted a loss of 122 million euros ($160 million) in 2011.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.